Treatment

This misuse of prescription opioids is a major public health challenge. Buprenorphine-naloxone (bup-nx) is typically used to treat opioid use disorders. However, the drug’s clinical trial primarily involved heroin users. It was therefore...

The over-prescription of opioids is a significant public health issue in the United States. For example, opioids are often prescribed for minor injuries unnecessarily. This, in turn, increases the risk of addiction. New research presented...

Thirteen years have passed since the US Food and Drug Administration (FDA) last approved a new medication to help the nation’s millions of people with alcohol use disorder (AUD) stop or moderate their drinking. Only 3 such formulations...

Background Screening and brief interventions for alcohol are an effective public health measure to tackle alcohol-related harm, however relatively few countries across the European Union (EU) have implemented them widely. This may be due to...

New research published in the Journal of Neural Transmission highlights a number of potential adverse side-effects from using the stimulant drug Ritalin without a prescription. Ritalin (Methylphenidate) is medically used to treat Attention...

The final row of the Alcohol Treatment Matrix enters the domain of treatment organised not primarily for the patient, but to safeguard the wider community, encountering what seems a core contradiction depicted on the cover of WHO guidance...